Actively Recruiting

Phase 4
Age: 18Years - 80Years
All Genders
NCT07000526

Inhaled Sedation in Critically Ill Patients

Led by Instituto de Investigación Hospital Universitario La Paz · Updated on 2026-03-02

620

Participants Needed

22

Research Sites

102 weeks

Total Duration

On this page

Sponsors

I

Instituto de Investigación Hospital Universitario La Paz

Lead Sponsor

I

Instituto de Salud Carlos III

Collaborating Sponsor

AI-Summary

What this Trial Is About

The proposal of this study is to compare inhaled sedation with isoflurane administered via the Sedaconda ACD-S system with intravenous sedation with propofol. Patients will be randomized 1:1 to receive either inhaled sedation with isoflurane administered via the Sedaconda ACD device (Sedana Medical, Uppsala, Sweden) or intravenous propofol. The primary endpoint is the number of ventilator-free days at 28 days after randomization.

CONDITIONS

Official Title

Inhaled Sedation in Critically Ill Patients

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients receiving mechanical ventilation, with an anticipated duration greater than 48 hours after randomization
  • Patients requiring deep sedation with a target Richmond Agitation Sedation Scale (RASS) score between -3 and -5
Not Eligible

You will not qualify if you...

  • Contraindication or allergy to isoflurane or propofol
  • Cardiopulmonary arrest
  • History of ventricular tachycardia or long QT syndrome
  • Tidal volume less than 300 mL or PaCO2 greater than 50 mmHg at randomization
  • Invasive mechanical ventilation for more than 48 hours at randomization
  • Pregnancy or breastfeeding
  • Acute neurological condition
  • Expected need for repeated surgical interventions during ICU stay
  • Use of ECMO or ECCO2R
  • Requirement for active humidification
  • Neuromuscular disease or high spinal cord injury likely to prevent ventilator discontinuation
  • Requirement for benzodiazepine use for a specific indication
  • Burns
  • Life expectancy less than 48 hours or very high risk of death during ICU stay
  • Any condition or language barrier preventing delirium or cognitive assessment
  • Lack of informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 22 locations

1

Hospital Vega Baja

Orihuela, Alicante, Spain

Actively Recruiting

2

Hospital Universitario Doctor José Molina Orosa

Arrecife, Lanzarote-Canary Islands, Spain, 35500

Not Yet Recruiting

3

Hospital Universitario de Albacete

Albacete, Spain

Not Yet Recruiting

4

Hospital Germans Trias i Pujol

Badalona, Spain

Not Yet Recruiting

5

Corporacio Sanitaria Parc Taulí

Barcelona, Spain

Not Yet Recruiting

6

Hospital Universitario de Bellvitge

Barcelona, Spain

Not Yet Recruiting

7

Hospital Universitario Valle de Hebron

Barcelona, Spain

Actively Recruiting

8

Hospital General Universitario Santa Lucía

Cartagena, Spain

Not Yet Recruiting

9

Hospital Arnau de Vilanova

Lleida, Spain

Not Yet Recruiting

10

Hospital Universitario La Paz

Madrid, Spain, 28029

Actively Recruiting

11

Hospital Univeritario Puerta de Hierro

Madrid, Spain

Not Yet Recruiting

12

Hospital Universitario de Getafe

Madrid, Spain

Not Yet Recruiting

13

Hospital Universitario de la Princesa

Madrid, Spain

Actively Recruiting

14

Hospital Universitario Gregorio Marañon

Madrid, Spain

Not Yet Recruiting

15

Hospital Universitario Infanta Leonor

Madrid, Spain

Actively Recruiting

16

Hospital Universitario Rey Juan Carlos

Madrid, Spain

Actively Recruiting

17

Hospital Reina Sofía

Murcia, Spain

Not Yet Recruiting

18

Hospital Universitario Virgen de la Arrixaca

Murcia, Spain

Not Yet Recruiting

19

Hospital Universitario Joan XXIII

Tarragona, Spain

Not Yet Recruiting

20

Hospital Universitario de Toledo

Toledo, Spain

Not Yet Recruiting

21

Hospital Clínico Universitario de Valencia

Valencia, Spain

Actively Recruiting

22

Hospital Universitario Rio Hortega

Valladolid, Spain

Actively Recruiting

Loading map...

Research Team

J

José M. Añón, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here